Showing results (91-100 of 1,282) with videos related to
Sort By:
Pageof 129
Diabetologia|December 28, 2016
PCSK9 inhibition: the dawn of a new age in cholesterol lowering?David Preiss, Marion MafhamJournal of Clinical Monitoring and Computing|July 9, 2008
A measure of confidence in Bland-Altman analysis for the interchangeability of two methods of measurementDavid Preiss, Joseph FisherBMJ Open|April 7, 2016
Health and social consequences of an alcohol-related admission to critical care: a qualitative studyJoanne McPeake, Ewan Forrest, Tara Quasim, et al.The Journal of Clinical Endocrinology and Metabolism|May 12, 2005
Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of dosesLyndal R Harborne, Naveed Sattar, Jane E Norman, et al.British Journal of Pharmacology|April 15, 2017
Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?Paul Welsh, Gianluca Grassia, Shani Botha, et al.Journal of the American College of Cardiology|May 27, 2017
Novel Diabetes Drugs and the Cardiovascular SpecialistNaveed Sattar, Mark C Petrie, Bernard Zinman, et al.Nature Reviews. Rheumatology|July 12, 2019
Cardiometabolic comorbidities in RA and PsA: lessons learned and future directionsLyn D Ferguson, Stefan Siebert, Iain B McInnes, et al.BJOG : an International Journal of Obstetrics and Gynaecology|November 1, 2003
Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart diseaseJane E Ramsay, Frances Stewart, Ian A Greer, et al.Lancet (London, England)|June 6, 2003
Descriptive review of the evidence for the use of metformin in polycystic ovary syndromeLyndal Harborne, Richard Fleming, Helen Lyall, et al.Circulation|December 12, 2022
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 DiabetesNikolaus Marx, Mansoor Husain, Michael Lehrke, et al.Pageof 129